Explore MCT: Join us in creating the most comprehensive platform for Myeloma Clinical Trials
- Patient Education: Reading
- Dec 1, 2023
- 2 min read
Updated: Feb 5, 2024
How to Navigate through MCT Website and find high yield topics.
You can also search any topic in search bar to find related posts.
Clinical Trials: Newly Diagnosed Multiple Myeloma
Clinical Trials: Patients with newly diagnosed Myeloma.
Clinical Trials: Relapsed & Refractory Multiple Myeloma
Clinical Trials: Patients with relapsed and refractory Myeloma.
Clinical Trials: MGUS & Smoldering Myeloma
Clinical Trials: Patients with smoldering Myeloma and MGUS (Monoclonal gammopathy of undetermined significance)
Multiple Myeloma Patient's Education
We are here to provide a seamless source of information for patients around the world to learn more about the disease, treatment options, and answers to FAQs that arise during treatment. We aim to empower patients and family members with knowledge through trusted sources in their fight against cancer.
Multiple Myeloma FDA Approved Drugs
Information on Drugs used for treatment of Multiple Myeloma.
Thank You for visiting:
Join us in creating the most comprehensive platform for researching Multiple Myeloma Trials, providing accurate and up-to-date information on all myeloma clinical trials, and raising awareness and education about Multiple Myeloma Treatment Options and Multiple Myeloma Clinical Trials.
Afshan Malik, MD
Myeloma Specialist, NYC
MISSION STATEMENT:
The passion to pursue excellence in treatment of Myeloma.
To provide a seamless source of information for patients all around the world to learn more about the disease, treatment options, and answers to frequently asked questions that arise during this journey and to empower patients and family members with knowledge through trusted sources in their fight against cancer.
To provide a useful resource for community oncologists involved in treating Myeloma patients to formulate Data Driven Individualized Treatment plans for patients, aiming for longer remissions, and turning remissions into cure.
To work in collaboration with Myeloma community organizations towards one common goal: CURE MYELOMA